Literature DB >> 21719689

D-dimer testing in laboratory practice.

Armando Tripodi1.   

Abstract

BACKGROUND: D-dimer is a reliable and sensitive index of fibrin deposition and stabilization. As such, its presence in plasma should be indicative of thrombus formation. There are many conditions unrelated to thrombosis in which D-dimer concentrations are high, however, making its positive predictive value rather poor. CONTENT: Notwithstanding these limitations, D-dimer can be regarded as a most valuable laboratory tool to diagnose and manage a vast array of thrombosis-related clinical conditions, including (a) diagnosis of venous thromboembolism (VTE), (b) identification of individuals at increased risk of first thrombotic event (both arterial and venous), (c) identification of individuals at increased risk of recurrent VTE, (d) establishment of the optimal duration of secondary prophylaxis after a first episode of VTE, (e) pregnancy monitoring, and (f) diagnosis/monitoring of disseminated intravascular coagulation (DIC). This article is aimed at reviewing the merits and pitfalls of these applications.
SUMMARY: From my analysis of the literature, I draw the following conclusions. (a) D-dimer, as measured by a sensitive test, can be safely used to exclude VTE in symptomatic outpatients, provided that it is used in combination with the pretest clinical probability. (b) High concentrations of D-dimer are associated with an increased risk of recurrent VTE. (c) Patients who present with D-dimer above cutoff after stopping the regular course of oral anticoagulation benefit from extended prophylaxis. (d) Finally, D-dimer can be used as a fibrin-related degradation marker for the diagnosis/management of patients with DIC.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21719689     DOI: 10.1373/clinchem.2011.166249

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  38 in total

1.  D-dimer as a marker of acute pyelonephritis in infants younger than 24 months with urinary tract infection.

Authors:  Jung Won Lee; Sun Mi Her; Ji Hong Kim; Keum Hwa Lee; Michael Eisenhut; Se Jin Park; Jae Il Shin
Journal:  Pediatr Nephrol       Date:  2018-01-06       Impact factor: 3.714

2.  Impact of D-dimer level on postinterventional coronary flow and in-hospital MACE in ST-segment elevation myocardial infarction.

Authors:  B Sarli; M Akpek; A O Baktir; O Sahin; H Saglam; H Arinc; H Odabasi; S Dogan; S Kurtul; Y Dogan; M G Kaya
Journal:  Herz       Date:  2014-01-19       Impact factor: 1.443

3.  Relationship of pericardial fat with biomarkers of inflammation and hemostasis, and cardiovascular disease: the Multi-Ethnic Study of Atherosclerosis.

Authors:  Kwok-Leung Ong; Jingzhong Ding; Robyn L McClelland; Bernard M Y Cheung; Michael H Criqui; Philip J Barter; Kerry-Anne Rye; Matthew A Allison
Journal:  Atherosclerosis       Date:  2015-01-31       Impact factor: 5.162

4.  Increased fibrinogen, D-dimer and galectin-3 levels in patients with migraine.

Authors:  Yavuz Yucel; Halis Tanriverdi; Adalet Arıkanoglu; Sefer Varol; Ibrahim Kaplan; Esref Akil; Tahsin Celepkolu; Ertugrul Uzar
Journal:  Neurol Sci       Date:  2013-09-22       Impact factor: 3.307

5.  D-dimer corrected for thrombin and plasmin generation is a strong predictor of mortality in patients with sepsis.

Authors:  Fabrizio Semeraro; Concetta T Ammollo; Pietro Caironi; Serge Masson; Roberto Latini; Mauro Panigada; Antonio Pesenti; Nicola Semeraro; Luciano Gattinoni; Mario Colucci
Journal:  Blood Transfus       Date:  2019-11-19       Impact factor: 3.443

6.  [Thrombosis and post-thrombotic syndrome as a consequence of an accident].

Authors:  U Wahl; T Hirsch
Journal:  Unfallchirurg       Date:  2015-10       Impact factor: 1.000

7.  Characterization of the yeast tricalbins: membrane-bound multi-C2-domain proteins that form complexes involved in membrane trafficking.

Authors:  C E Creutz; S L Snyder; T A Schulz
Journal:  Cell Mol Life Sci       Date:  2004-05       Impact factor: 9.261

8.  Basophil Blood Cell Count Is Associated With Enhanced Factor II Plasma Coagulant Activity and Increased Risk of Mortality in Patients With Stable Coronary Artery Disease: Not Only Neutrophils as Prognostic Marker in Ischemic Heart Disease.

Authors:  Francesca Pizzolo; Annalisa Castagna; Oliviero Olivieri; Domenico Girelli; Simonetta Friso; Filippo Stefanoni; Silvia Udali; Veronica Munerotto; Marcello Baroni; Vera Cetera; Giovanni Battista Luciani; Giuseppe Faggian; Francesco Bernardi; Nicola Martinelli
Journal:  J Am Heart Assoc       Date:  2021-02-24       Impact factor: 5.501

9.  Performance of D-dimer for predicting sepsis mortality in the intensive care unit.

Authors:  Yan-Qiu Han; Li Yan; Lei Zhang; Pei-Heng Ouyang; Peng Li; Giuseppe Lippi; Zhi-De Hu
Journal:  Biochem Med (Zagreb)       Date:  2021-06-15       Impact factor: 2.313

10.  Prognostic value of D-dimer for adverse outcomes in patients with infective endocarditis: an observational study.

Authors:  Ying-Wen Lin; Mei Jiang; Xue-Biao Wei; Jie-Leng Huang; Zedazhong Su; Yu Wang; Ji-Yan Chen; Dan-Qing Yu
Journal:  BMC Cardiovasc Disord       Date:  2021-06-05       Impact factor: 2.298

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.